Application of bayesian statistics to decision making during a clinical trial
- 1 January 1992
- journal article
- clinical trial
- Published by Wiley in Statistics in Medicine
- Vol. 11 (1) , 23-35
- https://doi.org/10.1002/sim.4780110105
Abstract
We describe the application of Bayesian methods to the monitoring and analysis of a trial of treatment for patients with advanced colorectal carcinoma. We discuss the choice of prior distribution and justify the use of a truncated normal distribution with a probability mass at zero difference. The stopping rule, based on the trials of the posterior distribution and a chosen range of equivalence, yields an upper boundary very close to the Pocock group sequential boundary. The Bayes stopping rule is quite sensitive to the amount of probability mass at zero in the prior distribution.Keywords
This publication has 13 references indexed in Scilit:
- Inference and decision in clinical trialsJournal of Clinical Epidemiology, 1989
- Comparison of Bayesian with group sequential methods for monitoring clinical trialsControlled Clinical Trials, 1989
- Testing a Point Null Hypothesis: The Irreconcilability of P Values and EvidenceJournal of the American Statistical Association, 1987
- Monitoring clinical trials: Conditional or predictive power?Controlled Clinical Trials, 1986
- Discrete Sequential Boundaries for Clinical TrialsBiometrika, 1983
- The Assessment of the Subjective Opinion and its Use in Relation to Stopping Rules for Clinical TrialsJournal of the Royal Statistical Society: Series D (The Statistician), 1983
- The asymptotic joint distribution of the efficient scores test for the proportional hazards model calculated over timeBiometrika, 1981
- A Bayesian Test of Some Classical Hypotheses, with Applications to Sequential Clinical TrialsJournal of the American Statistical Association, 1966